View in EDS HTML Full Text PDF Full Text

Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD.

Saved in:
Bibliographic Details
Title: Clinical course of severe COVID19 treated with tocilizumab and antivirals post‐allogeneic stem cell transplant with extensive chronic GVHD.
Authors: Mirgh, Sumeet1,2 (AUTHOR), Gokarn, Anant1,2 (AUTHOR), Punatar, Sachin1,2 (AUTHOR), Chichra, Akanksha1,2 (AUTHOR), Singh, Anuj1,2 (AUTHOR), Rajendra, Akhil1,2 (AUTHOR), Babu Goli, Vasu1,2 (AUTHOR), Trivedi, Bhakti2,3 (AUTHOR), Joshi, Amit1,2 (AUTHOR), Patkar, Nikhil2,4 (AUTHOR), Tembhare, Prashant2,4 (AUTHOR), Subramanian, P. G.2,4 (AUTHOR), Shetty, Nitin2,5 (AUTHOR), Chavan, Preeti2,6,7 (AUTHOR), Bhat, Vivek2,7 (AUTHOR), Gupta, Sudeep1,2 (AUTHOR), Khattry, Navin1,2 (AUTHOR) nkhattry@gmail.com
Source: Transplant Infectious Disease. Aug2021, Vol. 23 Issue 4, p1-5. 5p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13982273
DOI:10.1111/tid.13576